Furanosterols

Furanosterols (Furostanolic Saponins and Related Furanosteroids): A Comprehensive Reference

Terminological Note and Scope

The term furanosterols — and the closely related term furostanols — is used in both the scientific literature and the dietary supplement industry to denote a class of steroidal natural compounds characterized by a furan-ring–containing steroidal skeleton. The term encompasses two distinct but structurally related families: (1) furostanolic saponins (furostanols), which are plant-derived steroidal glycosides commercially important as dietary supplements, and (2) furanosteroids (furanosterols sensu stricto), a smaller group of highly oxygenated steroids produced predominantly by fungi, of significance in pharmacological research. This article covers both families, with emphasis on the furostanolic saponins as these are the principal form encountered in dietary supplement and nutraceutical contexts. Where evidence is limited to in-vitro or animal models, this is stated explicitly.

1. Identity and Chemical Classification

1.1 Furostanolic Saponins (Furostanols)

Steroidal saponins isolated from plants such as Tribulus terrestris include spirostanol saponins bearing a sugar chain linked to C-3, and furostanols carrying a sugar chain at C-3 and a D-glucose residue at C-26. Furostanols are thus defined by their characteristic open-chain F-ring (as opposed to the closed spirostanol F-ring), with a hydroxyl group at C-26 that bears a glucose residue. The aglycone core is the furostane skeleton — a C₂₇ steroidal backbone.

The spirostanol fraction from T. terrestris contains mainly diosgenin, tigogenin, and gitogenin as aglycones. In the furostanol fraction, the corresponding aglycones include the same sapogenins in their open-ring forms. T. terrestris is mainly composed of spirostanol and furostanol saponins of the chlorogenin, hecogenin, diosgenin, tigogenin, gitogenin, neogitogenin, ruscogenin, neohecogenin, and sarsasapogenin types.

The most prominent individual furostanol saponin is protodioscin, a diosgenin-based furostanol glycoside that is the principal bioactive compound standardized in commercial furostanol extracts. Protodioscin, a new saponin (5,6-dihydroprotodioscin, neoprotodioscin) and their respective sulfates were detected by HPLC-ELSD-ESI-MS methods in the aerial parts of Tribulus terrestris.

Other important individual furostanol saponins isolated from plant sources include the terrestrosides, terrestrinines, terrestrinones, and the recently described tribufurostanosides. Eight furostanol glycosides, including five undescribed compounds named tribufurostanosides A–E, and three known ones, were isolated from the fruits of Tribulus terrestris L.; their chemical structures were determined by IR, HR-ESI-MS, 1D- and 2D-NMR spectra. Two new furostanol glycosides named terrestrinones A1/A2 were also isolated from the fruits of T. terrestris L., together with four known compounds, with structures determined by spectroscopic methods including 2D NMR.

1.2 Furanosteroids (Furanosterols Sensu Stricto)

Furanosteroids, represented by wortmannin, viridin, and demethoxyviridin, are a special group of fungal-derived, highly oxygenated steroids featured by an extra furan ring. In fungi, the oxidative removal of carbons from sterol precursors also produces active molecules, such as wortmannin, viridin, and demethoxyviridin, which are called furanosteroids because all of these molecules contain an extra furan ring fused between C-4 and C-6 of the steroidal framework.

Furanosteroids are polycyclic natural products isolated from fungi, which consist of wortmannin and viridin containing a [5,6,6,6]-tetracyclic skeleton in addition to a furan ring. They inhibit phosphoinositide 3-kinases, suggesting drug potential. Viridin is an antifungal metabolite of Gliocladium virens that was first reported in 1945; belonging to the class of furanosteroids, it has a characteristic highly strained electrophilic furan ring fused between C-4 and C-6 of the steroid framework.

These fungal furanosteroids are not used as dietary supplements due to their potent cytotoxic and nonselective enzyme-inhibitory activities, but they are referenced here because they are the strict chemical definition of "furanosterol" and appear extensively in natural-products chemistry literature that overlaps with the supplement space.

2. Natural Sources and Botanical Identity

2.1 Plant Sources of Furostanolic Saponins

The primary plant sources of commercially relevant furostanolic saponins are:

• Trigonella foenum-graecum L. (fenugreek), family Fabaceae. Trigonella foenum-graecum, commonly known as fenugreek, is an herb from the Fabaceae family with a long history of use in traditional medicine across various cultures. The seeds of fenugreek contain a wide range of biologically active compounds including steroidal saponins (notably furostanol glycosides), alkaloids, flavonoids, polyphenols, amino acids, and trace minerals. Fenugreek seeds are the richest commercial source of furostanolic saponins, and standardized seed extracts enriched to ~20–40% furostanolic saponins form the basis of patented supplement products.
• Tribulus terrestris L. (puncture vine / goathead), family Zygophyllaceae. Tribulus terrestris L. is a perennial plant widely distributed around the world, especially in subtropical areas. T. terrestris contains various compounds including steroids, vitamins, alkaloids, unsaturated fatty acids, aspartic acid, saponins, tannins, flavonoids, resins, potassium nitrate, and glutamic acid. Furostanol saponins are found in the fruit, aerial parts, and roots, with the fruit being the richest source used in supplements.
• Dioscorea species (wild yam) also contain furostanol-type glycosides. Diosgenin and yamogenin are the most important steroidal sapogenins of fenugreek seed extract. These same sapogenins occur as aglycones in both Dioscorea and fenugreek furostanol saponins.

2.2 Fungal Sources of Furanosteroids

Furanosteroids and related isoprenoid lipids are derived from diverse terrestrial and marine sources. Fungi, fungal endophytes, plants, and various marine organisms, including sponges, corals, molluscs, and other invertebrates, have proven to be abundant reservoirs of these compounds.

Specific fungal producers include Gliocladium virens (viridin), Penicillium wortmanni Klocker (wortmannin — isolated from broth cultures in 1957), and Trichoderma virens, a filamentous fungus and biocontrol agent for various bacteria and fungi, which biosynthesizes viridin and viridiol. The biosynthetic gene cluster of demethoxyviridin was identified from Nodulisporium sp., a symbiotic fungus, whose whole genome was sequenced to identify a total of 103 cytochrome P450 monooxygenase genes.

3. Traditional and Historical Use

3.1 Fenugreek (Trigonella foenum-graecum)

In both Ayurvedic and Chinese medicine, fenugreek leaves and seeds have long been known for their therapeutic efficacy in diabetes, muscle building, and wrestling. Fenugreek seeds, abundant in furostanol saponins, have been utilized to support lactation, improve digestion, and manage blood sugar levels. The seeds and whole plant were preparations taken in both food and medicinal contexts; the seeds were consumed whole, as a ground spice, or decocted in water.

These compounds are known to exert hypoglycemic, hypolipidemic, and hormone-modulating effects, making fenugreek a promising candidate for managing metabolic and endocrine disorders.

3.2 Tribulus terrestris

Tribulus terrestris has been used for thousands of years as a well-known traditional medicine in China and is listed as a superior herbal medicine in the oldest extant Chinese pharmaceutical monograph "Shen Nong Ben Cao Jing." It has also been used since ancient times in traditional Indian medicine (Ayurveda), and in the traditional medicine of southeastern Europe for the treatment of different conditions.

It is used in traditional Chinese medicine and in Ayurveda for chest pain, heart-related problems, dizziness, skin and eye disorders, to expel kidney stones, and as a diuretic and tonic. Its fruits have been used in traditional Chinese medicine for treatment of eye problems, edema, abdominal distention, emission, morbid leucorrhea, sexual dysfunction, and veiling. It has also been used as a medicine in India, South Africa, and Japan.

This potent Ayurvedic medicine has been utilized for centuries in Ayurveda to address venereal disorders and sexual debility. Additionally, in Bulgaria, the plant is used as a traditional remedy for treating impotence. Furthermore, the root and fruit of this plant are recognized in the Ayurvedic Pharmacopoeia of India for their cardiotonic properties.

Tribulus terrestris is an annual herb that grows worldwide, especially in subtropical areas, and has been used in folk medicine in India, China, Bulgaria, and other countries against sexual impotency, edemas, abdominal distention, and cardiovascular diseases. Preparations containing T. terrestris extracts are on sale in the USA as food supplements claiming a general stimulating action on motor activity, muscle tone, and a restorative tonic for vigor. Indeed, T. terrestris preparations are mainly used to improve performance in sports and for the treatment of impotency.

In traditional preparations, the dried fruits of T. terrestris (called "Jili" in Chinese or "Gokshura" in Ayurveda) were typically decocted in water or taken as a dried powder. In Bulgarian folk medicine, a standardized extract became the basis of the commercial preparation "Tribestan," which launched in the 1980s and contributed to the widespread global interest in the plant as an androgenic tonic.

4. Key Constituents and Active Compounds

4.1 Furostanolic Saponins — Principal Compounds

The patented fenugreek seed extract Fenfuro is approximately 40% furostanolic saponins. Fenugreek seeds are known to contain soluble dietary fiber, protein, vitamin C, niacin, potassium, 4-hydroxyisoleucine, lysine and selected amino acids, L-tryptophan, and selected steroidal saponins including diosgenin, yamogenin, tigogenin, and neotigogenin, demonstrated to inhibit both cholesterol absorption in the intestine and cholesterol production by the liver.

The most pharmacologically studied furostanol saponin from both fenugreek and Tribulus terrestris is protodioscin. The medicinal herb fenugreek (Trigonella foenum-graecum) seeds, fortified with dietary fibers and furostanolic saponins including protodioscin, have demonstrated a significant contribution to human health. Furosap®, a patented 20% protodioscin-enriched extract, was developed from fenugreek seeds.

Other characterized furostanol saponins from T. terrestris include: terrestrosides A and B, two new furostanol saponins with complex sugar chains including rhamnose, glucose, galactose, and xylose moieties, isolated from the dry fruits of Tribulus terrestris. The more recently described tribufurostanosides A–E add five additional novel structures to the expanding library. Twelve new steroidal saponins, including eleven furostanol saponins (terrestrinin J–T) and one spirostanol saponin (terrestrinin U), together with seven known steroidal saponins, were isolated from T. terrestris.

4.2 Furanosteroids — Key Compounds (Research Relevance)

The realm of furanosteroids and related isoprenoid lipids derives from diverse terrestrial and marine sources. Fungi, fungal endophytes, plants, and various marine organisms — including sponges, corals, molluscs, and other invertebrates — have proven to be abundant reservoirs of these compounds. Notable individual compounds include:

• Wortmannin: Wortmannin has an IC₅₀ of 4.2 nM, making this compound one of the most potent naturally occurring PI3-kinase inhibitors known.
• Viridin: An antifungal metabolite of Gliocladium virens first reported in 1945, with a characteristic highly strained electrophilic furan ring fused between C-4 and C-6 of the steroid framework.
• Demethoxyviridin: produced by Nodulisporium sp. and studied for its biosynthetic gene cluster.
• Dysideasterols, nakiterpiosin, malabaricol, cortistatins: Marine-derived furanosteroids; the discovery of exceptional compounds such as nakiterpiosin, malabaricol, dysideasterols, and cortistatins has revealed their potent anti-tuberculosis, antibacterial, and anti-hepatitis C attributes. These compounds also exhibit activity in inhibiting protein kinase C, phospholipase A2, and eliciting cytotoxicity against cancer cells.

5. Established Mechanisms of Action

5.1 Furostanolic Saponins — Endocrine and Metabolic Mechanisms

The primary proposed mechanism by which furostanolic saponins influence androgen physiology relates to enzymatic modulation and steroidogenic pathway effects:

• 5-alpha-reductase modulation: Fenugreek's saponins, particularly protodioscin and furostanol glycosides, may support endogenous testosterone production by influencing steroidogenesis and modulating key enzymes like aromatase and 5-alpha reductase.
• Diosgenin as steroid precursor: Diosgenin and yamogenin are the most important steroidal sapogenins of fenugreek seed extract. Diosgenin in particular is shown as an important precursor for synthesizing steroidal hormones such as testosterone.
• Anti-diabetic mechanism: The anti-diabetic efficacy of fenugreek seed extract was attributed to the presence of furostanolic saponins and 4-hydroxyisoleucine. The amino acids present are useful in boosting insulin sensitization and glycogen synthesis. Dietary fibers and saponins that are present are specifically known to enhance hypoglycemic activity.
• Cholesterol absorption inhibition: Selected steroidal saponins including diosgenin, yamogenin, tigogenin, and neotigogenin have been demonstrated to inhibit both cholesterol absorption in the intestine and cholesterol production by the liver.

5.2 Anti-inflammatory Mechanism of Furostanol Saponins

Eight furostanol glycosides, including five undescribed compounds named tribufurostanosides A–E, were isolated from the fruits of Tribulus terrestris L. Furostanols 1–8 significantly inhibited nitric oxide production in LPS-activated RAW 264.7 cells with IC₅₀ values ranging from 14.2 to 64.7 μM, compared to the positive control compound dexamethasone (IC₅₀ 13.6 μM). Inhibition of nitric oxide production in macrophages is a recognized marker of anti-inflammatory activity; these data are from cell-culture (in vitro) models only.

5.3 Furanosteroids — PI3K Inhibition Mechanism

Furanosteroids, represented by wortmannin, viridin, and demethoxyviridin, are a special group of fungal-derived, highly oxygenated steroids featured by an extra furan ring. They are well-known nanomolar-potency inhibitors of phosphatidylinositol 3-kinase (PI3K) and widely used in biological studies.

The molecular mechanism of PI3K inhibition involves covalent modification: the amino group in a lysine side chain of phosphoinositide 3-kinases attacks the C-20 of the furan E ring to form a vinylogous carbamate, which irreversibly inhibits the enzyme. Wortmannin also inhibits other kinases, including PLK1 and DNA-PK. However, wortmannin is rapidly degraded in serum and exhibits general toxicity, hindering its development as a drug.

Furanosteroids strongly inhibit phosphatidylinositol 3-kinases, which are associated with tumor cell proliferation. Therefore, structure–activity relationship studies of furanosteroids can aid in the development of effective pesticides and therapeutics.

6. Scientific Evidence by Area of Use

The following sections address only furostanolic saponins (the dietary supplement form). For each area, human/clinical evidence is differentiated from preclinical (animal or in vitro) evidence. Evidence strength is characterized explicitly.

6.1 Male Reproductive Health and Testosterone

Human/clinical evidence:

A one-arm, open-labelled, multi-center study was conducted in 50 male volunteers (age: 35 to 65 years) over a period of 12 weeks to determine the efficacy of Furosap (500 mg/day/subject) on free and total testosterone levels, sperm profile, sperm morphology, libido and sexual health, mood and mental alertness, and broad-spectrum safety parameters. This study demonstrated that this novel, patented fenugreek seed extract (Furosap, FS), enriched in 20% protodioscin extract, is beneficial in significantly enhancing free testosterone level, sperm count, sperm motility, mental alertness, mood, reflex erection, and overall performance in human volunteers.

In a subsequent open-label, one-arm, single-center longitudinal study, the safety and efficacy of Furosap® on free and total testosterone levels, fasting blood sugar, blood pressure, sperm count, motility and morphology, DHEA-S, sexual health, reflex erection, mood alleviation, mental alertness, and total blood chemistry analyses were examined over a period of 12 weeks in healthy male volunteers.

A separate investigation evaluated the benefits of supplementation of a novel fenugreek seed extract enriched in 20% protodioscin (Furosap) on lean body mass, fat-free mass, serum testosterone level, systolic and diastolic blood pressures, cardiorespiratory endurance, and muscle strength in healthy subjects (age: 24.02 ± 3.90 years); 40 subjects were screened and randomly assigned to receive either placebo or Furosap capsules (250 mg each, twice daily) over a period of 12 consecutive weeks. The intervention with the placebo or fenugreek seed extract enriched in 20% protodioscin (Furosap) was assessed by whole-body DEXA measurements, with p<0.05 versus placebo, n=35.

Limitations and evidence strength: The human studies using Furosap are predominantly open-label (non-blinded), single-arm, or have small sample sizes. They are funded by or conducted at institutions with interests in the commercial product. No large-scale, independently funded randomized controlled trials with pre-registered endpoints have been published. Evidence should be characterized as preliminary and supportive but not conclusive.

6.2 Blood Glucose and Type 2 Diabetes

Human/clinical evidence:

Trigonella foenum-graecum (fenugreek) seeds are known to exhibit potent antioxidant, hypoglycemic, and nephroprotective activities, as well as serve as excellent membrane stabilizers, especially because of their content of novel furostanolic saponins.

A multicenter, randomized, placebo-controlled, double-blind, add-on clinical study evaluated over a period of 90 consecutive days the efficacy of Fenfuro (daily dosage: 500 mg bid) in 154 subjects (male: 108; female: 46; age: 25–60 years) with type 2 diabetes. The Fenfuro extract used was approximately 40% furostanolic saponins, manufactured through a patent-pending water–ethanol extraction process in a GMP-NSF certified plant. Fenfuro caused significant reduction in both fasting plasma and post-prandial blood sugar levels. Approximately 83% of the subjects reported decreases in fasting plasma sugar levels in the Fenfuro-treated group as compared to 62% in the placebo group, while 89% of the subjects demonstrated reduction in post-prandial plasma sugar levels in the Fenfuro-treated group as compared to 72% in the placebo group. HbA1c levels were reduced in both placebo and treatment groups; the decrease in HbA1c levels was significant in both groups as compared to respective baseline values. A significant increase in fasting and post-prandial C-peptide levels compared to respective baseline values was observed, while no significant changes in fasting and post-prandial C-peptide levels were observed between the two groups.

No significant adverse effects were observed by blood chemistry analyses.

Limitations and evidence strength: This RCT was conducted as an add-on study (subjects remained on existing antidiabetic medications), limiting attribution of effects solely to Furosap. The failure to achieve between-group significance for HbA1c and C-peptide weakens the conclusions about glycemic effects. A number of studies have demonstrated that fenugreek attenuated body weight gain and improved insulin sensitivity. The overall body of evidence for glycemic effects is moderate — more robust than for testosterone, but still requiring independent replication.

6.3 Anti-inflammatory Activity

Preclinical/in vitro evidence only:

Tribulus terrestris is a highly valuable traditional Chinese medicine used to treat stroke, inflammation, pulmonary fibrosis, liver cancer, and urolithiasis. To identify the basic substance responsible for the anti-inflammatory effect of total saponins of Tribulus (TST), its chemical composition was systematically studied, and its effect on inhibiting nitric oxide generation and the expression of related inflammatory factors were determined.

Eight furostanol glycosides from the fruits of T. terrestris had their chemical structures determined; furostanols 1–8 significantly inhibited nitric oxide production in LPS-activated RAW 264.7 cells with IC₅₀ values ranging from 14.2 to 64.7 μM, compared to the positive control dexamethasone (IC₅₀ 13.6 μM).

All isolates including terrestrinones were evaluated for their potential to inhibit the LPS-induced production of nitric oxide in murine macrophage RAW264.7 cells; compounds 2 and 3 inhibited nitric oxide production with IC₅₀ values of 7.1 and 46.6 μM.

Evidence strength: Anti-inflammatory evidence is currently in vitro only (cell culture models). There are no published human clinical trials evaluating furostanolic saponins specifically for inflammatory endpoints.

6.4 Cardiovascular Effects

Preclinical studies indicate that tribulus has analgesic, antihypertensive, anti-inflammatory, antiedematous, antioxidant, diuretic, hypoglycemic, antibacterial, antifungal, cardioprotective, and anticancer properties. Many pharmaceutical preparations with furostanolic and steroidal saponins as the active compound have been commercially available. Examples include "tribusaponins" and "Xin-nao-shu-tong," which have been used for the treatment of cardiovascular disease.

Broad-spectrum safety blood chemistry analyses showed no significant changes were observed in serum lipid function, cholesterol, triglyceride, HDL and LDL levels, and hemogram with the protodioscin-enriched extract (Furosap).

No significant changes were observed from baseline in fasting glucose, AST, ALT, serum creatinine, insulin, or total cholesterol levels between the placebo and Furosap groups.

Evidence strength: Most cardiovascular-relevant data from furostanolic saponins are preclinical. Cardiovascular safety parameters were neutral in human studies reviewed. No dedicated human RCTs targeting cardiovascular outcomes have been published for furostanolic saponins specifically.

6.5 Anticancer and Cytotoxic Activity

Preclinical evidence only:

The inhibitory effects of furostanol saponins from T. terrestris on tumour cells were evaluated, and compounds showed potential anti-tumour activity.

The biological activities exhibited by furanosteroids and related lipids encompass anticancer, cytotoxic effects against various cancer cell lines, antiviral, and antifungal effects.

In the domain of strict furanosteroids (wortmannin-type), wortmannin has been developed as a commercial PI3K inhibitor widely used in various biological studies, exemplified by the semisynthetic analogue PX-866, which was tested in a Phase II clinical trial for treating cancers. However, PX-866 and related furanosteroid analogues are experimental pharmaceutical compounds, not dietary supplements.

Evidence strength: Anticancer data for plant-derived furostanolic saponins are exclusively preclinical (in vitro and animal). No human clinical trials of furostanolic saponins for cancer treatment have been published. The PI3K-inhibitory furanosteroids (wortmannin, viridin) have undergone early pharmaceutical development for cancer but are not used as supplements.

6.6 Sperm Quality and Male Fertility

A patented fenugreek seed extract enriched in 20% protodioscin (Furosap) was shown to significantly enhance free testosterone level, sperm count, sperm motility, mental alertness, mood, reflex erection, and overall performance in human volunteers in the 12-week multi-center study. Administration of fenugreek seed extract to diabetic rats significantly decreased the sperm shape abnormality and improved the sperm count in animal studies.

Evidence strength: Sperm-quality data come from a single open-label human study and supporting animal data. Independent corroboration in blinded RCTs is needed.

7. Body Systems and Health Areas of Association

• Endocrine system: Modulation of androgens (testosterone, dihydrotestosterone, DHEA-S) via effects on steroidogenic enzymes; aromatase and 5-alpha-reductase.
• Reproductive system: Sperm parameters, libido, and male sexual function based on human open-label data; traditional use as an aphrodisiac across multiple traditions.
• Metabolic / glycemic regulation: Blood glucose and insulin sensitivity in type 2 diabetes, supported by one multicenter RCT and preclinical data.
• Cardiovascular system: Traditional use and preclinical data; safety parameters (cholesterol, triglycerides) were neutral in clinical studies.
• Immune / inflammatory: Nitric oxide inhibition demonstrated in vitro; no clinical anti-inflammatory trials.
• Musculoskeletal: Lean body mass; physical performance and muscle strength were investigated in one RCT. No significant changes were observed in jump height, grip-test, peak jump force, and peak push-up forces in subjects taking Furosap.
• Cellular signaling (research/pharmacological): PI3K pathway inhibition (wortmannin-type furanosteroids), relevant to oncology and inflammation research but not dietary supplementation.

8. Dosage Forms and Reported Dosages

The following dosages are reported in published studies only. They should not be interpreted as recommended doses.

• Furosap® (20% protodioscin fenugreek seed extract):
  • 500 mg per day, taken over 12 weeks, in male volunteers aged 35–65 years, in the open-label testosterone/sperm profile study.
  • 250 mg twice daily (total 500 mg/day) in capsule form, over 12 consecutive weeks, in the lean body mass RCT in healthy subjects aged ~24 years.
• Fenfuro™ (~40% furostanolic saponins fenugreek seed extract):
  • 500 mg twice daily (1,000 mg/day total) over 90 consecutive days in the multicenter T2D RCT in subjects aged 25–60.
• Dosage form: Furosap capsules were prepared in a GMP-NSF certified facility and administered orally.
• Standardization: Commercial preparations are typically standardized to furostanolic saponin content (20% or 40%) by HPLC analysis. A patent-pending water–ethanol extraction process was used to manufacture Fenfuro in a GMP-NSF certified manufacturing plant, enriched in approximately 40% furostanolic saponins.

9. Safety Considerations and Drug Interactions

9.1 Safety Profile from Human Studies

No significant changes were observed from baseline in the fasting glucose, AST, ALT, serum creatinine, insulin, or total cholesterol levels between the placebo and Furosap groups in the lean body mass RCT. No adverse events were reported in that study.

Broad-spectrum blood chemistry analyses revealed broad-spectrum safety. No significant changes were observed in serum lipid function, cholesterol, triglyceride, HDL and LDL levels, and hemogram in the 12-week open-label Furosap study, confirming that the protodioscin-enriched extract from fenugreek seeds (Furosap) is safe and efficacious in the parameters studied.

No significant adverse effects were observed by blood chemistry analyses in the Fenfuro T2D clinical trial.

9.2 Hepatorenal Toxicity Considerations (Spirostanol vs. Furostanol)

An important distinction in safety exists between spirostanol and furostanol saponins from T. terrestris. The spirostanol saponin terrestrosin D (TED), a major spirostanol saponin isolated from Fructus Tribuli, had potential hepatorenal toxicity in laboratory studies. The spirostanol saponin TED showed significant cytotoxicity in LO2 (liver) and 293T (kidney) cells in the range of 10.3–41.3 μM; the IC₅₀ values for LO2 and 293T cells were 16.88 μM and 21.80 μM after 24 h. In contrast, the furostanol saponins in the same study (terrestrosin K and related compounds) showed a different, more favorable toxicological profile, though in vitro cytotoxicity data must be interpreted cautiously relative to in vivo conditions.

9.3 Additive Hypoglycemic Risk

The Fenfuro clinical study was conducted as an add-on study in subjects already on antidiabetic medications. Given the demonstrated blood-glucose-lowering effects of furostanolic saponin extracts, additive or synergistic hypoglycemic effects are biologically plausible when co-administered with insulin or oral hypoglycemics. No formal pharmacokinetic drug-interaction studies have been published for furostanolic saponins with antidiabetic drugs.

9.4 Hormonal Interactions

Fenugreek's saponins, particularly protodioscin and furostanol glycosides, may support endogenous testosterone production by influencing steroidogenesis and modulating key enzymes like aromatase and 5-alpha reductase. This implies a theoretical interaction potential with exogenous hormone therapies, aromatase inhibitors, or 5-alpha-reductase inhibitors (e.g., finasteride). No clinical drug–interaction trials have been published.

9.5 Wortmannin and Related Furanosteroids — Toxicity

Wortmannin and its relatives are nonselective, highly toxic, and have a therapeutic index that makes it difficult to evaluate their in vivo activity as antitumor agents. These fungal furanosteroids are not used in dietary supplements due to their toxicity profile and are referenced here only for completeness regarding the broader furanosterol chemical family.

9.6 Product Quality and Standardization

Many pharmaceutical preparations and food supplements with steroidal saponins as the active compound have been commercially available. Not all commercial preparations are subject to the same standardization or testing protocols. The patented extraction processes described in published studies (Furosap, Fenfuro) were manufactured under GMP conditions, but the furostanolic saponin content in non-patented, generic "Tribulus" or "fenugreek" products may vary substantially.

10. Research Context: Furanosteroids in Drug Discovery

Members of the furanosteroid class of natural products have attracted significant attention for many years due to their potent anti-inflammatory and antibiotic properties and more recently because of their potential antiproliferative activities. The unique steroidal scaffold of furanosteroids, coupled with their exciting biological activities, prompted tremendous efforts by chemists to develop efficient synthetic strategies.

In 1945, Brian and co-workers isolated viridin from Gliocladium virens. In 1957, the same group isolated wortmannin from broth cultures of Penicillium wortmanni Klocker. The intriguing structures and excellent biological activities of furanosteroids led to extensive efforts toward their total chemical synthesis over the past 20 years, and the stereoselective synthesis of wortmannin and (−)-viridin was finally achieved in 2017.

Despite their importance, the biosyntheses of these molecules have been poorly understood. The identification of the biosynthetic gene cluster for demethoxyviridin, consisting of 19 genes (including 15 biosynthetic genes with six cytochrome P450 monooxygenase genes), represents a significant advance.

This comprehensive area of study emphasizes the significance of furanosteroids and related lipids as valuable natural products with promising therapeutic potential. The remarkable biodiversity found in both terrestrial and marine ecosystems offers an extensive resource for discovering novel biologically active compounds, paving the way for future drug development and advancements in biomedical research.

11. Summary of Evidence Strength

Across all areas of investigation, the following summarizes the current state of evidence for furostanolic saponins as dietary supplements:

• Glycemic effects in T2D: Moderate — supported by one multicenter double-blind RCT, though between-group HbA1c differences were not statistically significant.
• Testosterone and male reproductive health: Preliminary — supported by open-label, non-blinded, or small-sample studies; independent replication needed.
• Lean body mass: Inconclusive — statistically significant DEXA improvement in one RCT, but no significant effects on strength measures.
• Anti-inflammatory activity: Preclinical only — in vitro nitric oxide inhibition data; no human trials.
• Anticancer activity: Preclinical only — cell-culture cytotoxicity data; no human trials.
• Cardiovascular protection: Traditional use and preclinical; neutral safety profile in clinical studies.

References

• Dembitsky VM. Fascinating Furanosteroids and Their Pharmacological Profile. Molecules. 2023;28(15):5669. PMC10419491.
• Wang GQ et al. Biosynthetic pathway for furanosteroid demethoxyviridin and identification of an unusual pregnane side-chain cleavage. Nature Communications. 2018. doi:10.1038/s41467-018-04298-2.
• Recent progress in the synthesis of the furanosteroid family of natural products. Organic Chemistry Frontiers. 2021. doi:10.1039/D0QO01454K.
• Strategies for the Total Synthesis of the Furanosteroids: wortmannin and viridin. Chemistry Letters. 2021.
• Scalable preparation of furanosteroidal viridin, β-viridin and viridiol from Trichoderma virens. Scientific Reports. 2025.
• Anaya-Eugenio GD et al. Botanical Sources, Chemistry, Analysis, and Biological Activity of Furanocoumarins of Pharmaceutical Interest. Molecules. 2019;24(11):2163. PMC6600687.
• Maheshwari A et al. Efficacy of Furosap™, a novel Trigonella foenum-graecum seed extract, in Enhancing Testosterone Level and Improving Sperm Profile in Male Volunteers. Journal of Men's Health. 2017;14(2):58–66. PMC5278660.
• Safety and Efficacy of Furosap®, a Patented Trigonella foenum-graecum Seed Extract, in Boosting Testosterone Level, Reproductive Health and Mood Alleviation in Male Volunteers. Journal of the American Nutrition Association. 2022;42(1).
• Furosap, a novel Fenugreek seed extract improves lean body mass and serum testosterone in a randomized, placebo-controlled, double-blind clinical investigation. Functional Foods in Health and Disease. 2019.
• Gupta A et al. A multicenter clinical study to determine the efficacy of a novel fenugreek seed (Trigonella foenum-graecum) extract (Fenfuro™) in patients with type 2 diabetes. Food & Nutrition Research. 2016;60:32382. PMC5061863.
• Wang ZF et al. Furostanol and Spirostanol Saponins from Tribulus terrestris. Molecules. 2016;21(4):429. PMC6273128.
• A New Furostanol Glycoside from Tribulus terrestris. PMC6257061.
• Kiem PV et al. Five New Furostanol Glycosides from the Fruits of Tribulus terrestris with NO Production Inhibitory Activity. Chemistry & Biodiversity. 2024. doi:10.1002/cbdv.202401273.
• Promising phytopharmacology, nutritional potential, health benefits, and traditional usage of Tribulus terrestris L. herb. Heliyon. 2024.
• Terrestrosin D, a spirostanol saponin from Tribulus terrestris L. with potential hepatorenal toxicity. Journal of Ethnopharmacology. 2021.
• Furostanol saponins from Tribulus terrestris. Fitoterapia. 2003. doi:10.1016/j.fitote.2003.07.005.
• Tribulus terrestris — Memorial Sloan Kettering Cancer Center Integrative Medicine monograph.
• Fenugreek (Trigonella foenum-graecum) as a Natural Therapeutic Agent in Type 2 Diabetes, PCOS, and Testosterone Deficiency: A Consolidated Clinical Review. Medtigo Journal. 2026.